
- English
- PDF
- Available on iOS & Android
Heart Rate Slowing by If Current Inhibition
About this book
This book unfolds the history of the discovery of the transmembrane channel which is responsible for the 'funny' or If current, the primary modulator of heart rate. Inhibition of this current leads to slowing of the heart rate, which is an important component of the successful management of angina pectoris. Recently, Ivabradine, a specific and selective inhibitor of the If current, has been developed as an antianginal agent which has been shown to be at least as effective as both beta-blockers and calcium channel blockers for the treatment of angina. The development, efficacy and complications of this therapy are discussed in detail in this book. Furthermore, the clinical benefits from heart rate reduction in patients with coronary artery disease and heart failure and in patients after myocardial infarction are examined. Whether a lower heart rate per se will prolong life is not yet known, but it may offer a new and important life-saving strategy. The current data presented in this volume will be appreciated by cardiologists and general physicians interested in the modern management of angina pectoris and by electrophysiologists and physiologists who would like to understand the importance of heart rate and its regulation.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Contents
- Foreword
- Heart Rate: A Risk Factor for Cardiac Diseases and Outcomes?
- If Current Inhibition: Cellular Basis and Physiology
- Heart Rate Reduction by Pharmacological If Current Inhibition
- Clinical Perspectives of Heart Rate Slowing for Coronary Event Reduction and Heart Failure
- Clinical Effect of ‘Pure’ Heart Rate Slowing with a Prototype If Current Inhibitor: Placebo-Controlled Experience with Ivabradine
- Heart Rate Slowing versus Other Pharmacological Antianginal Strategies
- Novel If Current Inhibitor Ivabradine: Safety Considerations
- Heart Rate Slowing for Myocardial Dysfunction/Heart Failure
- Future Directions:What Data Do We Need?
- Author Index
- Subject Index